| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8477057 | Molecular and Cellular Endocrinology | 2015 | 8 Pages |
Abstract
TGF-β/Smad signaling pathway may play an important role in DA-resistant prolactinomas and has the potential to be a viable target for the diagnosis and treatment of prolactinomas, particularly in patients who are resistant to DAs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Zhenye Li, Qian Liu, Chuzhong Li, Xuyi Zong, Jiwei Bai, Youtu Wu, Xiaolei Lan, Guoqiang Yu, Yazhuo Zhang,